DTL | denticleless E3 ubiquitin protein ligase homolog (Drosophila) | 1q32 | 0.35 | 0.446 | 0
|
LIN9 | lin-9 DREAM MuvB core complex component | 1q42 | 0.344 | 0.507 | 0
|
PRR11 | proline rich 11 | 17q23.2 | 0.325 | 0.422 | 0
|
ASPM | abnormal spindle microtubule assembly | 1q31 | 0.319 | 0.477 | 0
|
NEK2 | NIMA-related kinase 2 | 1q32.3 | 0.319 | 0.46 | 0
|
CENPF | centromere protein F, 350/400kDa | 1q41 | 0.319 | 0.475 | 0
|
KIF14 | kinesin family member 14 | 1q32.1 | 0.316 | 0.453 | 0
|
DEPDC1B | DEP domain containing 1B | 5q12 | 0.316 | 0.321 | 1.42e-11
|
UCHL5 | ubiquitin carboxyl-terminal hydrolase L5 | 1q32 | 0.314 | 0.44 | 0
|
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | 15q15 | 0.309 | 0.385 | 2.48e-17
|
EXO1 | exonuclease 1 | 1q43 | 0.308 | 0.415 | 0
|
ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 | 1q32 | 0.307 | 0.594 | 0
|
BRCA2 | breast cancer 2, early onset | 13q13.1 | 0.305 | 0.392 | 0
|
WDHD1 | WD repeat and HMG-box DNA binding protein 1 | 14q22.2 | 0.304 | 0.364 | 9.09e-15
|
ECT2 | epithelial cell transforming 2 | 3q26.1-q26.2 | 0.304 | 0.399 | 0
|
KIF20B | kinesin family member 20B | 10q23.31 | 0.303 | 0.433 | 0
|
KIF11 | kinesin family member 11 | 10q24.1 | 0.303 | 0.427 | 0
|
IPO9 | importin 9 | 1q31.3 | 0.302 | 0.465 | 0
|
ARHGAP11A | Rho GTPase activating protein 11A | 15q13.3 | 0.302 | 0.405 | 0
|
PLK1 | polo-like kinase 1 | 16p | 0.302 | 0.331 | 3.11e-12
|
URB2 | URB2 ribosome biogenesis 2 homolog (S. cerevisiae) | 1q42.13 | 0.301 | 0.471 | 0
|
NUSAP1 | nucleolar and spindle associated protein 1 | 15q14 | 0.301 | 0.384 | 5.93e-17
|
IARS2 | isoleucyl-tRNA synthetase 2, mitochondrial | 1q41 | 0.3 | 0.466 | 0
|
TOP2A | topoisomerase (DNA) II alpha | 17q21.2 | 0.3 | 0.393 | 0
|
GTSE1 | G-2 and S-phase expressed 1 | 22q13.2-q13.3 | 0.3 | 0.365 | 7.46e-15
|
BROX | BRO1 domain and CAAX motif containing | 1q41 | 0.299 | 0.393 | 0
|
FBXO5 | F-box protein 5 | 6q25-q26 | 0.297 | 0.399 | 0
|
MMS22L | MMS22-like, DNA repair protein | 6q16.3 | 0.296 | 0.421 | 0
|
TMPO | thymopoietin | 12q22 | 0.295 | 0.403 | 0
|
NCAPG2 | non-SMC condensin II complex, subunit G2 | 7q36.3 | 0.295 | 0.406 | 0
|
MPHOSPH9 | M-phase phosphoprotein 9 | 12q24 | 0.293 | 0.433 | 0
|
PARP1 | poly (ADP-ribose) polymerase 1 | 1q41-q42 | 0.293 | 0.515 | 0
|
CENPL | centromere protein L | 1q25.1 | 0.292 | 0.357 | 3.39e-14
|
ESPL1 | extra spindle pole bodies like 1, separase | 12q13.13 | 0.292 | 0.366 | 7.17e-15
|
FAM83D | family with sequence similarity 83, member D | 20q11.23 | 0.291 | 0.384 | 5.38e-17
|
ANP32E | acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | 1q22 | 0.29 | 0.498 | 0
|
FAM72A | family with sequence similarity 72, member A | 1q32.1 | 0.29 | 0.46 | 0
|
MKI67 | marker of proliferation Ki-67 | 10q26.2 | 0.289 | 0.394 | 0
|
NUP133 | nucleoporin 133kDa | 1q42.13 | 0.289 | 0.474 | 0
|
RAD51AP1 | RAD51 associated protein 1 | 12p13.2-p13.1 | 0.289 | 0.379 | 3.49e-16
|
RBL1 | retinoblastoma-like 1 | 20q11.23 | 0.289 | 0.461 | 0
|
XPO1 | exportin 1 | 2p15 | 0.288 | 0.385 | 1.82e-17
|
EPRS | glutamyl-prolyl-tRNA synthetase | 1q41 | 0.286 | 0.439 | 0
|
USP1 | ubiquitin specific peptidase 1 | 1p31.3 | 0.285 | 0.412 | 0
|
CASP8AP2 | caspase 8 associated protein 2 | 6q15 | 0.284 | 0.448 | 0
|
RBBP5 | retinoblastoma binding protein 5 | 1q32 | 0.283 | 0.477 | 0
|
HEATR1 | HEAT repeat containing 1 | 1q43 | 0.282 | 0.436 | 0
|
HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 1q44 | 0.282 | 0.407 | 0
|
TEN1 | TEN1 CST complex subunit | 17q25.1 | 0.281 | -0.402 | 0
|
SDE2 | SDE2 telomere maintenance homolog (S. pombe) | 1q42.12 | 0.281 | 0.508 | 0
|
TUBGCP3 | tubulin, gamma complex associated protein 3 | 13q34 | 0.281 | 0.484 | 0
|
XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | 7q36 | 0.28 | 0.376 | 6.59e-16
|
H2AFV | H2A histone family, member V | 7p13 | 0.278 | 0.368 | 4.83e-15
|
RRP15 | ribosomal RNA processing 15 homolog | 1q41 | 0.277 | 0.442 | 0
|
LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor | 1p32.3 | 0.272 | 0.369 | 3.61e-15
|
NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | 2q33-q34 | 0.272 | 0.27 | 1.6e-08
|
LRRCC1 | leucine rich repeat and coiled-coil centrosomal protein 1 | 8q21.2 | 0.271 | 0.27 | 1.64e-08
|
CCSAP | centriole, cilia and spindle-associated protein | 1q42.13 | 0.271 | 0.427 | 0
|
KIF23 | kinesin family member 23 | 15q23 | 0.269 | 0.362 | 1.45e-14
|
NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 1q32.1 | 0.268 | 0.487 | 0
|
TAF1A | TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa | 1q42 | 0.268 | 0.389 | 0
|
TAF5L | TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 1q42.11-q42.3 | 0.267 | 0.483 | 0
|
C4orf48 | chromosome 4 open reading frame 48 | 4p16.3 | 0.266 | -0.369 | 3.43e-15
|
LENG9 | leukocyte receptor cluster (LRC) member 9 | 19q13.42 | 0.263 | -0.413 | 0
|
NCAPD3 | non-SMC condensin II complex, subunit D3 | 11q25 | 0.262 | 0.403 | 0
|
TTK | TTK protein kinase | 6q14.1 | 0.262 | 0.381 | 2.07e-16
|
HMMR | hyaluronan-mediated motility receptor (RHAMM) | 5q34 | 0.261 | 0.38 | 2.87e-16
|
LMNB1 | lamin B1 | 5q23.2 | 0.261 | 0.408 | 0
|
LYRM9 | LYR motif containing 9 | 17q11.2 | 0.261 | -0.243 | 3.84e-07
|
DHRS7B | dehydrogenase/reductase (SDR family) member 7B | 17p12 | 0.256 | -0.37 | 2.8e-15
|
UBL5 | ubiquitin-like 5 | 19p13.2 | 0.252 | -0.394 | 0
|
AHCTF1 | AT hook containing transcription factor 1 | 1q44 | 0.251 | 0.444 | 0
|
ARRDC1 | arrestin domain containing 1 | 9q34.3 | 0.244 | -0.363 | 1.16e-14
|
ENAH | enabled homolog (Drosophila) | 1q32.2 | 0.244 | 0.399 | 0
|
NSL1 | NSL1, MIS12 kinetochore complex component | 1q41 | 0.242 | 0.41 | 0
|
TSNAX | translin-associated factor X | 1q42.2 | 0.241 | 0.465 | 0
|
DNAJC30 | DnaJ (Hsp40) homolog, subfamily C, member 30 | 7q11.23 | 0.236 | -0.334 | 1.92e-12
|
HSCB | HscB mitochondrial iron-sulfur cluster co-chaperone | 22q12.1 | 0.233 | -0.234 | 1.08e-06
|
FBXO28 | F-box protein 28 | 1q42.12 | 0.229 | 0.334 | 1.75e-12
|
ARHGAP19 | Rho GTPase activating protein 19 | 10q24.2 | 0.226 | 0.384 | 5.02e-17
|
UHRF1BP1 | UHRF1 binding protein 1 | 6p21.31 | 0.224 | 0.331 | 2.84e-12
|
PGM3 | phosphoglucomutase 3 | 6q14.1-q15 | 0.222 | 0.254 | 1.11e-07
|
MFSD5 | major facilitator superfamily domain containing 5 | 12q13.13 | 0.222 | -0.395 | 0
|
PM20D2 | peptidase M20 domain containing 2 | 6q15 | 0.221 | 0.356 | 4.86e-14
|
DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 10p14 | 0.22 | 0.219 | 5.3e-06
|
HMGB1P1 | high mobility group box 1 pseudogene 1 | 20q13 | 0.219 | 0.312 | 5.57e-11
|
C2orf48 | chromosome 2 open reading frame 48 | 2p25.1 | 0.219 | 0.289 | 1.41e-09
|
SPATA7 | spermatogenesis associated 7 | 14q31.3 | 0.218 | -0.272 | 1.36e-08
|
UAP1 | UDP-N-acetylglucosamine pyrophosphorylase 1 | 1q23.2 | 0.217 | 0.268 | 2.2e-08
|
LPGAT1 | lysophosphatidylglycerol acyltransferase 1 | 1q32.3 | 0.216 | 0.346 | 2.62e-13
|
ANKK1 | ankyrin repeat and kinase domain containing 1 | 11q23.2 | 0.216 | -0.343 | 4.32e-13
|
TMUB2 | transmembrane and ubiquitin-like domain containing 2 | 17q21 | 0.215 | -0.299 | 3.53e-10
|
TBCE | tubulin folding cofactor E | 1q42.3 | 0.212 | 0.294 | 7.41e-10
|
PRRG2 | proline rich Gla (G-carboxyglutamic acid) 2 | 19q13.33 | 0.209 | -0.396 | 0
|
SDF2 | stromal cell-derived factor 2 | 17q11.2 | 0.207 | -0.279 | 5.29e-09
|
DDX59 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 | 1q32.1 | 0.205 | 0.327 | 5.61e-12
|
FH | fumarate hydratase | 1q42.1 | 0.204 | 0.312 | 5.63e-11
|
GGN | gametogenetin | 19q13.2 | 0.203 | -0.281 | 4.17e-09
|
TERT | telomerase reverse transcriptase | 5p15.33 | 0.203 | 0.16 | 0.000895
|
SPRYD4 | SPRY domain containing 4 | 12q13.3 | 0.2 | -0.279 | 5.56e-09
|
SERPINB6 | serpin peptidase inhibitor, clade B (ovalbumin), member 6 | 6p25.2 | 0.2 | -0.185 | 0.000121
|
DKK4 | dickkopf WNT signaling pathway inhibitor 4 | 8p11.2-p11.1 | 0.199 | -0.249 | 1.94e-07
|
MAGED2 | melanoma antigen family D2 | Xp11.2 | 0.191 | -0.177 | 0.000239
|
AUTS2 | autism susceptibility candidate 2 | 7q11.22 | 0.191 | 0.183 | 0.000148
|
DAP3 | death associated protein 3 | 1q22 | 0.189 | 0.214 | 8.63e-06
|
TP53INP2 | tumor protein p53 inducible nuclear protein 2 | 20q11.22 | 0.189 | -0.082 | 0.0917
|
C4orf3 | chromosome 4 open reading frame 3 | 4q26 | 0.188 | -0.12 | 0.0131
|
FCHSD2 | FCH and double SH3 domains 2 | 11q13.3 | 0.187 | 0.255 | 1.01e-07
|
C9orf3 | chromosome 9 open reading frame 3 | 9q22 | 0.184 | -0.186 | 0.000116
|
FBXO25 | F-box protein 25 | 8p23.3 | 0.183 | -0.219 | 5.06e-06
|
EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 6q24 | 0.182 | 0.145 | 0.00271
|
GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 9p13.1 | 0.182 | 0.278 | 5.98e-09
|
CNNM1 | cyclin and CBS domain divalent metal cation transport mediator 1 | 10q24.2 | 0.18 | 0.038 | 0.436
|
TMEM185A | transmembrane protein 185A | Xq28 | 0.18 | -0.261 | 4.72e-08
|
PADI1 | peptidyl arginine deiminase, type I | 1p36.13 | 0.18 | -0.126 | 0.00901
|
GNPAT | glyceronephosphate O-acyltransferase | 1q42 | 0.18 | 0.334 | 1.74e-12
|
TP53I3 | tumor protein p53 inducible protein 3 | 2p23.3 | 0.172 | -0.304 | 1.75e-10
|
BRF2 | BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit | 8p11.23 | 0.164 | -0.049 | 0.309
|